Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

Development and Characterization of Colon Targeting Curcumin Nanoparticles

Shailja Gour*, B. K. Dubey, Brijesh Mishra

Technocrats Institute of Technology-Pharmacy, Bhopal (Madhya Pradesh)

ABSTRACT

Inflammatory Bowel Disease (IBD) cannot be controlled effortlessly and the reappearance is the most challenging issue for the physicians. There are various controlled and colon targeted drug delivery systems available for the treatment with limited success rate. Nanoparticles prepared by using the colon targeted polymers such as chitosan may improve the IBD due to their smaller size, unique physico chemical properties and targeting potential. The results of measurement of mean particle size of optimized formulation F2 nanoparticles were found 86.23 nm. When the regression coefficient values of were compared, it was observed that ‘r’ values of Pappas was maximum i.e. 0.949 hence indicating drug release from formulations was found to follow Pappas kinetics. . Eudragit-coated chitosan nanoparticles can be a promising carrier for colon-targeted delivery of Curcumin found to have high encapsulation efficiency and predetermined in vitro release profile.

Keywords: Inflammatory Bowel Disease, Curcumin, Chitosan, Eudragit-coated.


[Full Text Article]